Skip to main content

Biological Markers and the Molecular Biology of Frailty

  • Conference paper

Part of the book series: Research and Perspectives in Longevity ((RPL))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allolio B, Arlt W (2002) DHEA treatment: myth or reality? Trends Endocrinol Metab 13(7): 288–294.

    PubMed  CAS  Google Scholar 

  • Aragno M, Mastrocola R, Brignardello E, Catalano M, Robino G, Manti R, Parola M, Danni O, Boccuzzi G (2002) Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats. Endocrinology 143: 3250–3258.

    Article  PubMed  CAS  ISI  Google Scholar 

  • Buchner DM, Wagner EH (1992) Preventing frail health. Clin Geriatr Med 1992;8(1): 1–17.

    CAS  Google Scholar 

  • Campisi J (2003) Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 38: 5–11.

    Article  PubMed  CAS  Google Scholar 

  • Cappola AR, Bandeen-Roche K, Wand GS, Volpato S, Fried LP (2001) Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 86(9): 4139–4146. Ershler WB, Keller ET (2000) Age-associated increased interleukin-6 gene expression, latelife diseases, and frailty. Annu Rev Med 51:245-270.

    Article  PubMed  CAS  Google Scholar 

  • Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ (1999) Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 47: 639–646.

    PubMed  CAS  Google Scholar 

  • Fried LP, Tangen C, Walston J, Newman A, Hirsch CH, Gottdiener JS, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: evidence for a phenotype. J Gerontol 56A:M146–156

    Google Scholar 

  • Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Jr. Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106: 506–512.

    Article  PubMed  CAS  Google Scholar 

  • Kim Sh SH, Kaminker P, Campisi J (2002) Telomeres, aging and cancer: in search of a happy ending. Oncogene 21: 503–511.

    CAS  ISI  Google Scholar 

  • Leng S, Chaves P, Koenig K, Walston J (2002) Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 50: 1268–1271.

    Article  PubMed  Google Scholar 

  • Leng S, Huanle Y, Walston J (2004) Decreased cell proliferation and altered cytokine production in frail older adults. Aging Clin Exp Res 16: 249–252.

    PubMed  CAS  Google Scholar 

  • Morley JE, Kaiser FE, Perry HM, III, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ (1997) Longitudinal changes in testosterone, luteinizing hormone, and folliclestimulating hormone in healthy older men. Metabolism 46: 410–413.

    Article  PubMed  CAS  ISI  Google Scholar 

  • Roubenoff R (1997) Inflammatory and hormonal mediators of cachexia. J Nutr 127(5 Suppl): 1014S–1016S.

    PubMed  CAS  Google Scholar 

  • Seeman TE, Robbins RJ (1994) Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 15: 233–260.

    Article  PubMed  CAS  Google Scholar 

  • Souza-Pinto NC, Bohr VA (2002) The mitochondrial theory of aging: involvement of mitochondrial DNA damage and repair. Int Rev Neurobiol 53: 519–534.

    PubMed  Google Scholar 

  • Thompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Ghiron L, Hoffman AR (1995) The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 80: 1845–1852.

    PubMed  CAS  Google Scholar 

  • Walston J (2004) Frailty—the search for underlying causes. Sci Aging Knowledge Environ 2004(4):e4.

    Google Scholar 

  • Walston J, McBurnie MA, Newman A, Tracy R, Kop WJ, Hirsch CH, Gottdiener J, Fried LP, Cardiovascular Health Study (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical morbidities: Results from the Cardiovascular Health Study. Arch Intern Med 162: 2333–2341.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Walston, J.D. (2005). Biological Markers and the Molecular Biology of Frailty. In: Carey, J.R., Robine, JM., Pierre Michel, J., Christen, Y. (eds) Longevity and Frailty. Research and Perspectives in Longevity. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27388-3_7

Download citation

Publish with us

Policies and ethics